HERON THERAPEUTICS, INC. /DE/ — Operating Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2e4e0120-62d9-4277-b07d-8d525eb2d00f/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-2.5M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-073515 |
| FY 2024 | $-11.5M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-028374 |
| FY 2023 | $-110.6M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-029951 |
| FY 2022 | $-174.7M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-010603 |
| FY 2021 | $-217.8M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-007618 |
| FY 2020 | $-228.2M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-007841 |
| FY 2019 | $-210.7M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-007973 |
| FY 2018 | $-183.9M | 2018-01-01 – 2018-12-31 | evidence 0001193125-19-047780 |
| FY 2017 | $-194.6M | 2017-01-01 – 2017-12-31 | evidence 0001193125-18-060951 |
| FY 2016 | $-170.9M | 2016-01-01 – 2016-12-31 | evidence 0001193125-17-054088 |
| FY 2015 | $-96.9M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-469890 |
| FY 2014 | $-74.6M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-091072 |
| FY 2013 | $-54.5M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-087658 |
| FY 2012 | $-23.8M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-085823 |
| FY 2011 | $-11.1M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-132146 |
| FY 2010 | $-9.9M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-132146 |
| FY 2009 | $-10.2M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-132146 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
HERON THERAPEUTICS, INC. /DE/ — all facts · Revenue · Net Income